Form 4: GoodRx Holdings Executive Douglas Hirsch Reports Stock Transactions

Douglas Joseph Hirsch, Chief Mission Officer at GoodRx Holdings, reported the acquisition and disposal of Class A and Class B common stock on June 1, 2024.

Summary

• On June 1, 2024, Douglas Joseph Hirsch, Chief Mission Officer of GoodRx Holdings, engaged in transactions involving the company's stock.
• Hirsch acquired 126,552 shares of Class A Common Stock at $0 per share.
• Following these transactions, Hirsch directly owns 5,265,442 shares of Class A Common Stock.
• He also reported transactions involving Restricted Stock Units and Class B Common Stock, convertible into Class A Common Stock.
• These transactions included the conversion of 256,594 Restricted Stock Units into Class B Common Stock, then into Class A Common Stock, and the disposal of 130,042 Class B Common Stock for Class A Common Stock at a price of $7.87.
• Additionally, 126,552 Class B Common Stock were converted into Class A Common Stock at $0.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, which is a common occurrence in publicly traded companies. It provides transparency to investors regarding insider activity.

Stakeholder Impact

• The reported transactions provide transparency to shareholders regarding the insider activity of a key executive.

Key Dates